Table 3.
Relationship Between the Expression of SPARC and Clinicopathological Features of Endometrial Cancer Patients
| Clinicopathological Features | N | SPARC Low (-/+) |
SPARC High (++/+++) |
Χ2 | P | ||
|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | ||||
| Age | 0.942 | 0.332 | |||||
| ≤65 | 56 | 42 | 75.0 | 14 | 25.0 | ||
| >65 | 189 | 153 | 81.0 | 36 | 19.0 | ||
| Pathological type | 0.658 | 0.720 | |||||
| Endometrioid | 191 | 150 | 78.5 | 41 | 21.5 | ||
| Serous | 38 | 32 | 84.2 | 6 | 15.8 | ||
| Clear-cell | 16 | 13 | 81.3 | 3 | 18.7 | ||
| Cell differentiation | 15.194 | 0.000 | |||||
| Well | 131 | 92 | 70.2 | 39 | 29.8 | ||
| Poorly | 114 | 103 | 90.4 | 11 | 9.6 | ||
| FIGO stage | 11.680 | 0.001 | |||||
| Stages I and II | 144 | 104 | 72.2 | 40 | 27.8 | ||
| Stages III and IV | 101 | 91 | 90.0 | 10 | 10.0 | ||
| Nodal status | 8.411 | 0.004 | |||||
| Positive | 87 | 78 | 89.7 | 9 | 10.3 | ||
| Negative | 158 | 117 | 74.1 | 41 | 25.9 | ||